Stuart Poulton

Evp, Chief Development Officer at Karyopharm Therapeutics Inc. (KPTI), 2025-03-06

Insider Trading: Sales See All

Company	Symbol	Price	Amount	Remaining Holdings	Date	Form 4
Karyopharm Therapeutics Inc.	KPTI	$6.29	3,548	27,414	2025-03-04	Filing
Karyopharm Therapeutics Inc.	KPTI	$0.63	5,914	320,714	2025-02-18	Filing
Karyopharm Therapeutics Inc.	KPTI	$1.06	2,883	326,628	2024-07-30	Filing
Karyopharm Therapeutics Inc.	KPTI	$1.20	6,155	329,511	2024-03-01	Filing
Karyopharm Therapeutics Inc.	KPTI	$1.17	16,311	335,666	2024-02-29	Filing